Bisphosphonates as a treatment modality in osteoarthritis

Area of Science:

• Rheumatology and Pharmacology
• Biomedical Research

Background:

• Osteoarthritis (OA) is a prevalent global condition with limited disease-modifying treatments.
• Current OA management relies on pain relief, physical therapy, and joint replacement surgery.
• Bisphosphonates exhibit potential for OA treatment, targeting key pathogenic mechanisms.

Purpose of the Study:

• To evaluate the potential of bisphosphonates as disease-modifying agents for osteoarthritis.
• To analyze the efficacy of bisphosphonates in preclinical OA models and human clinical trials.
• To discuss discrepancies between animal study results and human clinical trial outcomes.

Main Methods:

• Review of in vitro and animal studies demonstrating bisphosphonate effects on OA pathogenesis.
• Analysis of six human clinical studies investigating bisphosphonate efficacy in OA patients.
• Discussion of factors contributing to the observed differences in efficacy between species.

Main Results:

• In vitro and animal studies show bisphosphonates modulate subchondral bone turnover, edema, cartilage degeneration, and synovitis.
• Bisphosphonates demonstrated clear efficacy in animal models of osteoarthritis.
• Only one of six human clinical studies showed clear short-term efficacy for bisphosphonates in OA.

Conclusions:

• Bisphosphonates target crucial OA pathogenesis pathways, showing promise in preclinical research.
• Clinical efficacy of bisphosphonates for osteoarthritis in humans remains largely unproven.
• Further research is needed to understand and address the discrepancies in bisphosphonate efficacy between animal models and human trials.